Charleston, SC -- (SBWIRE) -- 09/06/2013 -- Today’s Penny Stocks wants you, the investor, to have the ability to be informed in your trading decisions. Our website is designed to take you to the information you need to be at the top of your game in trading penny stocks. Today’s Penny Stocks issues news updates on the following stock: Dendreon Corporation (NASDAQ:DNDN), Forest Oil Corporation (NYSE:FST), Arena Pharmaceuticals, Inc. (NASDAQ:ARNA), Array Biopharma Inc (NASDAQ:ARRY).
Dendreon Corporation (NASDAQ:DNDN) showing bearish movement during previous trade, ended its day with the loss of -2.73% and closed at the price of $2.85, after opening at $2.92. Stock exchanged hands during its last trading session with the total volume of 2,531,225 shares, as compared to its average volume of 5.23 million shares. Dendreon Corporation, a biotechnology company, engages in the discovery, development, and commercialization of novel therapeutics to enhance cancer treatment options for patients. Its product portfolio includes active cellular immunotherapy and small molecule product candidates to treat a range of cancers.
Has DNDN Found The Bottom and Ready To Move Up? Find Out Here
FST, the company was showing upward momentum during the previous trading session. Forest Oil Corporation (NYSE:FST) reported the increase of 1.28%, to close at $5.52, with the overall traded volume of 2,678,840 shares. During last trade, the company’s minimum price was $5.42, while it touched its highest price of $5.67. Forest Oil Corporation, an independent oil and gas company, engages in the acquisition, exploration, development, and production of oil, natural gas, and natural gas liquids primarily in North America. Its principal areas are located in the Texas Panhandle Area, the Eagle Ford Shale in South Texas, and the East Texas/North Louisiana Area.
For How Long FST’s Gloss will Attract Investors? Find out via this report
Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) moving down during prior trade, closed at the price of $6.50, after opening at $6.53. Stock traded during its last trading session with the total volume of 2,480,662 shares, as compared to its average volume of 4.51 million shares. Arena Pharmaceuticals, Inc., a biopharmaceutical company, engages in discovering, developing, and commercializing novel drugs that target G protein-coupled receptors in the therapeutic areas of cardiovascular, central nervous system, inflammatory, and metabolic diseases.
Why Should Investors Buy ARNA After the Recent Fall? Just Go Here and Find Out
Array Biopharma Inc (NASDAQ:ARRY) was showing a bearish trend during the previous trading session, reported the decrease of -3.56%, to close at $5.69, and exchange hands with the overall traded volume of 2,415,854 shares. During last trade, the company’s minimum price was $5.68, while it touched its highest price of $5.98. Array BioPharma Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of small molecule drugs to treat patients afflicted with cancer and inflammatory diseases primarily in North America, Europe, and the Asia Pacific.
Will ARRY Get Buyers Even After The Recent Rally? Find Out Here
About Today’s Penny Stocks:
Today’s Penny Stocks wants you, the investor, to have the ability to be informed in your trading decisions. Our website is designed to take you to the information you need to be at the top of your game in trading penny stocks. Today’s wants you to do your own due diligence on your investments please use our site to find the information you need on whichever investment you choose.
The disclaimer is to be read and fully understood before using our site, or joining our newsletter email list. Never invest into a stock discussed on this web site or the TodaysPennyStocks.com newsletter unless you can afford to lose your entire investment.
Please consult with a certified financial advisor before making any investment decisions.
TodaysPennyStocks.com is owned and operated by FlipVentures LLC. We are engaged in the business of advertising and promoting companies for monetary compensation. All content in our releases is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. Neither the information presented nor any statement or expression of opinion, or any other matter herein, directly or indirectly constitutes a solicitation of the purchase or sale of any securities.
Read Full Disclaimer at: http://todayspennystocks.com/disclaimer/
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)